Bio-Thera will obtain an upfront payment of $21m and could earn up to $143.5m in development and commercial milestones.

Eli Lilly has shared positive two-year results from an open-label extension (OLE) study of Omvoh (mirikizumab-mrkz) in active ...

Class A shares underperformed the MSCI ACWI ex USA Index. During the quarter, we initiated four new positions and exited one ...

Queensland has the third highest prevalence of a debilitating bowel disease that impacts 180,000 Australians, costing sufferers thousands of dollars in medical expenses.

Bio-Thera had entered into an exclusive licensing agreement with STADA Arzneimittel AG to commercialize BAT2506 in the European Union (UK), the United Kingdom (UK), Switzerland, and selected other ...

One woman has shared how she started getting violent allergic reactions when eating certain foods. Lisa O'Brien said she started getting a red rosacea-like rash across her face which followed shortly ...

A recent major OECD report has warned of a looming crisis in the European health workforce. In the third in our series on the ...

HC Wainwright reissued their buy rating on shares of Immix Biopharma (NASDAQ:IMMX – Free Report) in a report released on ...

Until her mid-40s Lisa O'Brien gave little thought to what she ate - but suddenly certain foods started to trigger strange, ...

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven brokerages that are currently covering the company, Marketbeat reports. Two ...

Turmeric and honey contain beneficial compounds that can help reduce inflammation, improve metabolic health, and aid in weight loss.

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...